S&P 500   3,922.73 (-1.90%)
DOW   33,452.93 (-1.46%)
QQQ   281.13 (-2.26%)
AAPL   142.51 (-2.81%)
MSFT   244.40 (-2.32%)
META   114.41 (-6.55%)
GOOGL   96.80 (-2.69%)
AMZN   88.45 (-2.81%)
TSLA   179.23 (-1.76%)
NVDA   159.20 (-4.15%)
NIO   13.24 (+3.44%)
BABA   91.13 (+0.67%)
AMD   69.89 (-5.07%)
T   19.11 (+1.92%)
MU   53.47 (-1.05%)
CGC   3.65 (-15.51%)
F   13.19 (-1.42%)
GE   84.70 (+0.05%)
DIS   92.39 (-3.69%)
AMC   6.79 (-8.86%)
PYPL   72.02 (-2.17%)
PFE   49.60 (-2.23%)
NFLX   305.15 (-2.38%)
S&P 500   3,922.73 (-1.90%)
DOW   33,452.93 (-1.46%)
QQQ   281.13 (-2.26%)
AAPL   142.51 (-2.81%)
MSFT   244.40 (-2.32%)
META   114.41 (-6.55%)
GOOGL   96.80 (-2.69%)
AMZN   88.45 (-2.81%)
TSLA   179.23 (-1.76%)
NVDA   159.20 (-4.15%)
NIO   13.24 (+3.44%)
BABA   91.13 (+0.67%)
AMD   69.89 (-5.07%)
T   19.11 (+1.92%)
MU   53.47 (-1.05%)
CGC   3.65 (-15.51%)
F   13.19 (-1.42%)
GE   84.70 (+0.05%)
DIS   92.39 (-3.69%)
AMC   6.79 (-8.86%)
PYPL   72.02 (-2.17%)
PFE   49.60 (-2.23%)
NFLX   305.15 (-2.38%)
S&P 500   3,922.73 (-1.90%)
DOW   33,452.93 (-1.46%)
QQQ   281.13 (-2.26%)
AAPL   142.51 (-2.81%)
MSFT   244.40 (-2.32%)
META   114.41 (-6.55%)
GOOGL   96.80 (-2.69%)
AMZN   88.45 (-2.81%)
TSLA   179.23 (-1.76%)
NVDA   159.20 (-4.15%)
NIO   13.24 (+3.44%)
BABA   91.13 (+0.67%)
AMD   69.89 (-5.07%)
T   19.11 (+1.92%)
MU   53.47 (-1.05%)
CGC   3.65 (-15.51%)
F   13.19 (-1.42%)
GE   84.70 (+0.05%)
DIS   92.39 (-3.69%)
AMC   6.79 (-8.86%)
PYPL   72.02 (-2.17%)
PFE   49.60 (-2.23%)
NFLX   305.15 (-2.38%)
S&P 500   3,922.73 (-1.90%)
DOW   33,452.93 (-1.46%)
QQQ   281.13 (-2.26%)
AAPL   142.51 (-2.81%)
MSFT   244.40 (-2.32%)
META   114.41 (-6.55%)
GOOGL   96.80 (-2.69%)
AMZN   88.45 (-2.81%)
TSLA   179.23 (-1.76%)
NVDA   159.20 (-4.15%)
NIO   13.24 (+3.44%)
BABA   91.13 (+0.67%)
AMD   69.89 (-5.07%)
T   19.11 (+1.92%)
MU   53.47 (-1.05%)
CGC   3.65 (-15.51%)
F   13.19 (-1.42%)
GE   84.70 (+0.05%)
DIS   92.39 (-3.69%)
AMC   6.79 (-8.86%)
PYPL   72.02 (-2.17%)
PFE   49.60 (-2.23%)
NFLX   305.15 (-2.38%)
NASDAQ:HSIC

Henry Schein - HSIC Stock Forecast, Price & News

$80.86
-0.61 (-0.75%)
(As of 12/6/2022 03:14 PM ET)
Add
Compare
Today's Range
$80.21
$81.79
50-Day Range
$65.74
$83.29
52-Week Range
$64.75
$92.68
Volume
19,359 shs
Average Volume
1.14 million shs
Market Capitalization
$10.96 billion
P/E Ratio
17.58
Dividend Yield
N/A
Price Target
$84.67

Henry Schein MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
5.5% Upside
$84.67 Price Target
Short Interest
Bearish
3.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.35
Upright™ Environmental Score
News Sentiment
0.43mentions of Henry Schein in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
4.76%
From $4.83 to $5.06 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Medical Sector

892nd out of 1,023 stocks

Medical & Hospital Equipment Industry

3rd out of 3 stocks

HSIC stock logo

About Henry Schein (NASDAQ:HSIC) Stock

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Stock News Headlines

Henry Schein's (HSIC) New Deal to Improve Patient Outcome
Henry Schein to Present at Upcoming Investor Conferences
Henry Schein (HSIC) Surpasses Q3 Earnings Estimates
Henry Schein (NASDAQ: HSIC)
See More Headlines
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Company Calendar

Last Earnings
11/02/2021
Today
12/06/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/21/2023

Industry, Sector and Symbol

Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Sector
Medical
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
21,600
Year Founded
1932

Price Target and Rating

Average Stock Price Forecast
$84.67
High Stock Price Forecast
$99.00
Low Stock Price Forecast
$72.00
Forecasted Upside/Downside
+4.7%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
8 Analysts

Profitability

Net Income
$631.23 million
Pretax Margin
6.75%

Debt

Sales & Book Value

Annual Sales
$12.40 billion
Cash Flow
$5.95 per share
Book Value
$29.30 per share

Miscellaneous

Free Float
134,193,000
Market Cap
$10.96 billion
Optionable
Optionable
Beta
0.83

Social Links


Key Executives

  • Mr. Stanley M. BergmanMr. Stanley M. Bergman (Age 72)
    Exec. Chairman & CEO
    Comp: $5.02M
  • Mr. James P. BreslawskiMr. James P. Breslawski (Age 68)
    Exec. Vice Chairman & Pres
    Comp: $2M
  • Mr. Steven  PaladinoMr. Steven Paladino (Age 65)
    Exec. Director
    Comp: $1.68M
  • Mr. Mark E. MlotekMr. Mark E. Mlotek (Age 66)
    Exec. VP, Chief Strategic Officer & Exec. Director
    Comp: $1.49M
  • Mr. Ronald N. South (Age 60)
    Sr. VP & CFO
  • Mr. Michael Saul EttingerMr. Michael Saul Ettinger (Age 61)
    Exec. VP & COO
  • Ms. Olga Timoshkina
    VP of Corp. Fin., Chief Accounting Officer & Corp. Controller
  • Mr. Christopher Pendergast (Age 58)
    Sr. VP & CTO
  • Graham Stanley
    VP of Investor Relations & Strategic Fin. Project Officer
  • Mr. Walter  SiegelMr. Walter Siegel (Age 62)
    Sr. VP & Chief Legal Officer













HSIC Stock - Frequently Asked Questions

Should I buy or sell Henry Schein stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 1 sell rating, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings
or view top-rated stocks.

What is Henry Schein's stock price forecast for 2023?

8 Wall Street analysts have issued 12-month price objectives for Henry Schein's shares. Their HSIC share price forecasts range from $72.00 to $99.00. On average, they expect the company's share price to reach $84.67 in the next year. This suggests a possible upside of 3.9% from the stock's current price.
View analysts price targets for HSIC
or view top-rated stocks among Wall Street analysts.

How have HSIC shares performed in 2022?

Henry Schein's stock was trading at $77.53 on January 1st, 2022. Since then, HSIC stock has increased by 5.1% and is now trading at $81.47.
View the best growth stocks for 2022 here
.

Are investors shorting Henry Schein?

Henry Schein saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 5,290,000 shares, an increase of 6.0% from the October 31st total of 4,990,000 shares. Based on an average trading volume of 997,300 shares, the short-interest ratio is currently 5.3 days. Approximately 4.0% of the company's shares are short sold.
View Henry Schein's Short Interest
.

When is Henry Schein's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our HSIC earnings forecast
.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) issued its earnings results on Tuesday, November, 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.94 by $0.16. The company had revenue of $3.18 billion for the quarter, compared to the consensus estimate of $2.94 billion. Henry Schein had a net margin of 5.06% and a trailing twelve-month return on equity of 15.48%. During the same quarter in the prior year, the firm earned $1.03 earnings per share.
Read the conference call transcript
.

When did Henry Schein's stock split?

Henry Schein shares split before market open on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly created shares were distributed to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein announced that its Board of Directors has initiated a share repurchase program on Thursday, August 18th 2022, which permits the company to repurchase $400,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to reacquire up to 4% of its shares through open market purchases. Shares repurchase programs are often a sign that the company's management believes its stock is undervalued.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein issued an update on its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided EPS guidance of $4.79-$4.87 for the period, compared to the consensus earnings per share estimate of $4.84. The company issued revenue guidance of $12.59 billion-$12.71 billion, compared to the consensus revenue estimate of $12.89 billion.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.53%), BlackRock Inc. (7.81%), Longview Partners Guernsey LTD (5.23%), State Street Corp (5.12%), Pendal Group Ltd (3.24%) and Macquarie Group Ltd. (1.80%). Insiders that own company stock include Deborah Derby, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Mark E Mlotek, Michael S Ettinger, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends
.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $81.47.

How much money does Henry Schein make?

Henry Schein (NASDAQ:HSIC) has a market capitalization of $11.04 billion and generates $12.40 billion in revenue each year. The company earns $631.23 million in net income (profit) each year or $4.60 on an earnings per share basis.

How many employees does Henry Schein have?

The company employs 21,600 workers across the globe.

Does Henry Schein have any subsidiaries?
The following companies are subsidiares of Henry Schein: ACE Surgical Supply Co., ADS Florida, AUV Veterinary Services, Accord, Alpha Scientific, Arcade Dentaire, Arseus, Arseus Dental Solutions, Arseus Lab, Becker-Parkin Dental Supply, BioHorizons Inc., Butler Schein Animal Health, C&M Vetlink, Camlog USA Inc., DNA Anthos Impianti, Dental Cremer, Dental Trey, Elite Computer Italia, Exan Enterprises Inc., General Injectables & Vaccines Inc., HS Brand Management Inc., HS TM Holdings LLC, Handpiece Parts & Repairs Inc., Henry Schein Europe Inc., Henry Schein Latin America Pacific Rim Inc., Henry Schein Medical Systems Inc., Henry Schein Practice Solutions Inc., Jorgen Kruuse, Lincoln Dental Supply, Logiciel Julie, Maddox Practice Group, Maravet, Marrodent, Medivet, Medka, Minerva Dental Limited, Modern Laboratory Services, NLS Animal Health, Noviko, Ortho Organizers, Ortho Technology, Project Helium Holdings LLC, Project Spartan Holdings Corp., RxWorks, SG Healthcare Corp, Sirona Direct, SmartPak Equine LLC, Software of Excellence, Sogim Grimouille, Southern Anesthesia & Surgical, The Exan Group, Veterinary Instrumentation, Vetstreet, W. & J. Dunlop, and scil animal care.
Read More
How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The official website for the company is www.henryschein.com. The company can be reached via phone at (631) 843-5500, via email at steven.paladino@henryschein.com, or via fax at 631-843-5541.

This page (NASDAQ:HSIC) was last updated on 12/6/2022 by MarketBeat.com Staff